Central Drug Research Institute is a premier R&D Institute under the aegis of Council of Scientific and Industrial Research (CSIR), New Delhi which is an autonomous body under Department of Scientific and Industrial Research, Government of India. The institute is engaged in the development of new drugs and diagnostics in various therapeutic areas like malaria, tuberculosis, filarial, leishmania, cancer, thrombosis, hypertension, dementia, diabetes, lipid disorders, gastric ulcer, osteoporosis, prostatic hyperplasia, etc.
The Indian drug regulators has withdrawn the alert on avastin which was imposed after off-label use of drug and recent cases of blindness. The office of DCG(I) was requested to take necessary measures to withdraw the Alert Notice issued on 21.01.2016 which was primarily issued as a precautionary measure in the light of the incidences of blindness reported in Gujarat.



